For those familiar with diabetes technology, the Omnipod platform from Insulet (Nasdaq:PODD) is one most will know about. Omnipod 5 — the world’s first available tubeless, wearable, automated insulin delivery system — is one of the leading pumps on the market. But, for those less familiar with the technology, Insulet has found new ways to […]
Diabetes
Medtrum touts meal logging tech for automated insulin delivery
Medtrum has shared findings supporting its technology for handling mealtime insulin delivery through its automated system. In a LinkedIn post, the China-based company touted its new solution for eliminating the need for carb counting for people with type 1 diabetes. It hopes to reduce the guesswork in mealtime decisions for people with diabetes, who often […]
PharmaSens reports positive findings for all-in-one insulin patch pump with CGM
PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. It features the sensor within the Niia device’s insulin infusion cannula. Existing patch […]
Modular Medical wins FDA clearance for Pivot tubeless insulin patch pump
Modular Medical (Nasdaq:MODD) announced today that it received FDA 510(k) clearance for its next-generation insulin patch pump. Pivot, a tubeless patch pump, consists of two parts, with a 3 mL reservoir and a disposable battery. It features smartphone connectivity for bolus and monitoring, plus electronic accuracy without tubes or constant wear. The pump requires no […]
FDA labels MiniMed insulin pump recall Class II
The FDA recently published a Class II recall related to insulin pump systems made by MiniMed (Nasdaq:MMED). Class II recalls constitute a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. MiniMed is […]
Insulet names J&J Medtech veteran as new SVP, chief quality, regulatory & compliance officer
Insulet (Nasdaq:PODD) announced on social media today that it appointed a new SVP, chief quality, regulatory and compliance officer. The company picked medical device industry veteran Chuck Medovich to take on the role. Medovich brings more than 30 years of experience across quality, regulatory, manufacturing and R&D functions. His track record includes more than two […]
ViCentra expects no immediate impact from Dexcom G6 discontinuation on Kaleido pump users
ViCentra told customers that it expects no immediate impact from Dexcom’s planned discontinuation of the G6 CGM line. At the end of 2025, Dexcom had a posting on its website stating that it would soon cease manufacturing for its G6 continuous glucose monitor (CGM). After July 1, 2026, the company plans to no longer manufacture the […]
A look at the tech behind the world’s first year-long CGM with Senseonics
Long-term implantable continuous glucose monitor (CGM) innovation is abundant at Senseonics (Nasdaq:SENS). The Germantown, Maryland-based company launched Eversense 365, its implantable CGM in 2024. Eversense 365 rests under the skin for the duration of a year. Users can change the device’s external, silicone-based adhesive daily with almost no skin reactions. Eversense 365 is also an […]
West Pharmaceutical Services opens expanded Dublin facility for injectable therapies
West Pharmaceutical Services (NYSE:WST) announced the opening of a new facility for contract services in Dublin, Ireland. IDA Ireland, the foreign direct investment arm for the Irish government, shared the announcement of the Damastown site’s opening. The 165,000-square-foot expansion enhances West’s contract services. It helps meet the growing demand for high-volume treatments, including for diabetes […]
Construction completed on Dexcom CGM manufacturing facility in Ireland
An Irish construction company said on LinkedIn that it completed work on a Dexcom (Nasdaq:DXCM) facility in Athenry, Ireland. John Paul Construction posted that it completed the Dexcom Medical Devices Facility, a state-of-the-art manufacturing and office development, putting the finishing touches on a 25-month program to build the facility for the San Diego-based continuous glucose […]
